TransMedics Selects Gogo Galileo HDX for Nationwide Organ Transport Fleet
TransMedics has chosen Gogo Galileo HDX to provide high-performance inflight connectivity for its fleet of 22 Embraer Phenom 300E aircraft used for organ transport.
Stocks · News reference
TransMedics Group, Inc. announced it will release its financial results for the third quarter of 2026 after the market closes on November 5, 2026.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
TransMedics has chosen Gogo Galileo HDX to provide high-performance inflight connectivity for its fleet of 22 Embraer Phenom 300E aircraft used for organ transport.
https://www.axios.com/2026/10/20/kidney-care-plan-kennedy
Canaccord Genuity analyst Jason Mills maintains TransMedics Group (NASDAQ:TMDX) with a Buy and lowers the price target from $95 to $94.